MedTrace Logo

ERAS Lazio Network Clinical Registry

NCT03353311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-09

No results posted yet for this study

Summary

Enhanced recovery after surgery (ERAS) protocols are programs aiming to implement patients recovery following surgical procedures developed about 25 years ago. ERAS protocols are based on a multi-disciplinary approach encompassing surgery, anesthesiology, nutrition and nursing; each specialty has to fulfill a number of items which have been demonstrated to reduce morbidity rates, hospital stay and to implement functional recovery comparing standard approach. Accordingly, ERAS society developed a Guidelines for a number of procedures, including colorectal.

The aim of this study is to evaluate the adherence over the last years to these protocols in eight Department of Surgery in Rome in a series of colorectal cancer patients.

Secondary aims are to investigate the correlation of the items adherence with surgical outcome and to establish a network of hospitals aiming to promote ERAS approach on a regional base.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliera "Sant'Andrea"

    collaborator OTHER

  • Policlinico Casilino ASL RMB

    collaborator OTHER

  • San Giovanni Addolorata Hospital

    collaborator OTHER

  • Campus Bio-Medico University

    collaborator OTHER

  • Ospedale San Paolo Civitavecchia

    collaborator UNKNOWN

  • Ospedale Cristo Re - Roma

    collaborator UNKNOWN

  • S.Eugenio Hospital

    collaborator OTHER

  • PERSIANI ROBERTO

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2017-10-01
Completion
2017-11-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03353311 on ClinicalTrials.gov